Healthcare > Medical Devices & Equipment
•437 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (437)
%
| Company | Market Cap | Price |
|---|---|---|
|
MediBeacon’s FDA-approved TGFR system is a diagnostic device for real-time kidney function assessment.
|
$58.58M |
$4.41
+6.27%
|
|
The company produces diagnostic equipment and imaging instruments (DeepView System) used for wound assessment.
|
$57.42M |
$2.23
-8.79%
|
|
Cardiology devices: portable 12-lead ECG synthesis device used for cardiac monitoring.
|
$55.78M |
$1.65
-6.78%
|
|
HOPE Therapeutics aims to acquire interventional psychiatry clinics and operate hospital-like services, aligning with Hospital Services.
|
$54.81M |
$3.17
-11.70%
|
|
Core product is a medical imaging-enabled superficial radiation therapy system (SRT-100 Vision) used for skin cancers and related conditions, relying on imaging for treatment planning.
|
$53.94M |
$3.28
-3.81%
|
|
Biodesix provides blood-based diagnostic tests (Nodify and VeriStrat), i.e., liquid biopsy tests for lung nodules/cancer.
|
$53.64M |
$7.32
-6.75%
|
|
Vitargus is an ophthalmology device used in vitreous surgery, placing ABVC in the Ophthalmology Devices category.
|
$50.99M |
$3.04
-7.03%
|
|
Clyra Medical infection-control devices imply use of diagnostic/medical equipment offerings.
|
$49.44M |
$0.16
-4.65%
|
|
Biomaterial products derived from placenta (e.g., placental matrix) used in wound care are a direct Celularity offering.
|
$49.10M |
$2.05
-3.76%
|
|
VolitionRx's Nu.Q platform constitutes a liquid biopsy diagnostic approach that measures circulating nucleosomes for cancer and NETosis-related conditions.
|
$47.81M |
$0.46
-10.75%
|
|
The company offers outsourced laboratory testing plus advisory and regulatory compliance support as part of its services.
|
$47.75M |
$1.39
-6.08%
|
|
IceCure designs and sells cryoablation medical devices (ProSense/XSEN), a core product category in medical devices.
|
$47.72M |
$0.87
-11.28%
|
|
OneRF platform includes FDA-cleared diagnostic mapping and EEG recording capabilities, which constitute diagnostic equipment.
|
$47.33M |
$0.95
-7.77%
|
|
NiCO laser pulse oximeter is a diagnostic/measurement device used at the point of care for oxygenation and co-oximetry assessments.
|
$41.73M |
$1.38
-4.17%
|
|
Directly manufactures dental devices (Wand/STA) and related consumables for dental procedures.
|
$40.71M |
$0.52
-5.69%
|
|
BDMD manufactures microwave ablation systems and disposable MWA needles used for tumor ablation, which fits the Surgical Equipment product category.
|
$39.73M |
$1.58
-3.07%
|
|
Core non-invasive neuromodulation devices (gammaCore, Quell, Sparrow Ascent, TAC-STIM) are the company's direct product offerings.
|
$37.10M |
$5.00
-5.12%
|
|
The company references proprietary diagnostic platforms and labeling/detection technologies used for molecular testing, aligning with diagnostic equipment.
|
$36.59M |
$0.70
|
|
Elutia develops and sells implant-associated surgical envelopes (EluPro) used during operative procedures, a core surgical equipment product category.
|
$36.18M |
$0.89
+1.02%
|
|
The company’s processing and storage activities imply access to laboratory testing/advisory services in supporting cord blood banking operations.
|
$35.77M |
$4.43
+0.35%
|
|
Develops and sells in vitro diagnostic (IVD) kits for brain diseases using metabolomics and machine learning (diagnostic products).
|
$35.75M |
$2.02
|
|
Directly manufactures/provides a surgical robotic system (surgical equipment).
|
$34.64M |
$5.84
-10.43%
|
|
Diagnostic equipment capabilities as part of potential medical device manufacturing.
|
$34.55M |
$3.21
-3.60%
|
|
Remote patient monitoring and ongoing health engagement across conditions.
|
$33.62M |
$15.30
-2.24%
|
|
Myomo's core product is the MyoPro myoelectric orthotic device, a prosthetics/implant category enabling upper-limb movement.
|
$33.50M |
$0.91
-12.50%
|
|
VECTR System for minimally invasive surgeries places Rafael Medical Devices in Surgical Equipment.
|
$33.38M |
$1.34
-1.47%
|
|
POCI designs and manufactures customized components and subsystems for medical devices (micro-optics, assemblies).
|
$33.16M |
$4.33
|
|
Equipment-based health services may utilize diagnostic equipment for health screening and related activities.
|
$31.08M |
$0.08
|
|
Direct cardiology ablation devices (vCLAS system) used for VT treatment.
|
$31.07M |
$2.02
-14.04%
|
|
Acquisition of Bethesda Medical expands diagnostic imaging within BMGL's healthcare ecosystem.
|
$30.27M |
$1.64
+1.86%
|
|
Core product category consists of safety syringes with retraction technology, a primary revenue driver.
|
$29.18M |
$0.97
-7.17%
|
|
Pathology Services / Laboratory testing is a core, directly-provided service offering.
|
$28.79M |
$19.04
-7.65%
|
|
The company uses a diagnostic test (ECHO) for ecDNA in its trials, aligning with the Liquid Biopsy category.
|
$27.53M |
$1.23
-0.81%
|
|
Prosthetics & Implants: regenerative breast implant and rhCollagen-based implants.
|
$25.20M |
$2.20
-6.38%
|
|
Nortech focuses on complex electromedical devices and markets, aligning with Medical Devices & Biometrics.
|
$24.85M |
$9.00
-0.86%
|
|
CNSide Diagnostics offers laboratory testing services (LDTs) for CSF-based tumor enumeration and biomarkers.
|
$24.42M |
$0.72
-7.07%
|
|
The company provides laboratory services related to DRP algorithms and testing.
|
$24.28M |
$1.61
-8.52%
|
|
MSC Lung Test is a blood-based diagnostic approach (miRNA signature) consistent with liquid biopsy testing.
|
$23.64M |
$1.47
+2.85%
|
|
IB-Stim and RED represent neuromodulation-related medical devices, a core device category the company directly designs/manufactures.
|
$22.95M |
$3.18
-1.24%
|
|
Pharmacy equipment and some medical devices sold through healthcare operations qualify NXPL as a medical devices/biometrics-related distributor.
|
$22.64M |
$0.87
-0.51%
|
|
LuViva is a diagnostic equipment device used for cervical cancer screening and monitoring.
|
$22.48M |
$0.28
+16.67%
|
|
ProPhase Labs directly provides Laboratory Testing & Advisory Services via BE-Smart diagnostic testing.
|
$21.85M |
$0.53
+1.29%
|
|
Directly produces ophthalmology device (SCS Microinjector) used for suprachoroidal injection delivery.
|
$20.62M |
$3.98
-8.72%
|
|
Offers Laboratory Testing & Advisory Services related to regulatory compliance and GLP data for decontamination validation.
|
$20.22M |
$1.01
+1.01%
|
|
The company leverages hydrogel-based materials for wound care applications, fitting the Wound Care Devices category.
|
$19.67M |
$2.57
-3.02%
|
|
Envoy Medical's Acclaim Cochlear Implant and Esteem FI-AMEI are implanted prosthetic devices designed to treat hearing loss.
|
$18.87M |
$0.89
-8.29%
|
|
Ovaprene, DARE-HRT1, DARE-LARC1 and related vaginal health products are device- or instrument-based offerings, aligning with Diagnostic Equipment / Medical Devices & Equipment in healthcare.
|
$18.76M |
$2.12
-4.93%
|
|
Mesh MEA organoid platform and preclinical monitoring systems function as diagnostic/lab instruments for research and testing.
|
$18.55M |
$0.42
-5.64%
|
|
Spryng is an orthopedic joint-therapy device used for osteoarthritis in dogs and horses.
|
$18.52M |
$1.28
+1.35%
|
|
Company designs and manufactures the Vivos Method dental oral appliances for obstructive sleep apnea, categorized under dental equipment.
|
$18.38M |
$3.12
+0.65%
|
|
IRIDEX directly manufactures and markets ophthalmology laser devices and related surgical ophthalmic equipment (e.g., MicroPulse, Endpoint Management, PASCAL/G6 systems).
|
$17.46M |
$1.04
-7.14%
|
|
Pulmatrix's iSPERSE platform includes a dry powder inhaler technology, a medical device component that aligns with Diagnostic Equipment as a related category.
|
$17.42M |
$4.77
+1.27%
|
|
Cuprina's MEDIFLY maggot debridement therapy and collagen/leech wound-care products are direct wound-care devices.
|
$17.28M |
$0.96
-12.73%
|
|
Directly manufactures and sells surgical hemostatic gauze used in human surgery (CelluSTAT).
|
$17.01M |
$0.07
-7.78%
|
|
Femasys develops and manufactures diagnostic equipment used for fallopian tube assessment and related gynecologic diagnostics (e.g., FemVue, FemCerv, FemChec, FemCath).
|
$16.68M |
$0.61
-8.12%
|
|
Company's RF spectroscopy hardware and non-invasive diagnostic platform constitute a diagnostic equipment product line.
|
$16.05M |
$2.14
+3.88%
|
|
AI Nose-derived odor detection capabilities are used as diagnostic equipment in health monitoring contexts.
|
$15.66M |
$3.77
-4.80%
|
|
D-PLEX100 is a localized antibacterial/surgical-site infection prevention product used in surgery, aligning with Surgical Equipment.
|
$15.11M |
$3.15
-3.96%
|
|
Core medical device product: swallowable intragastric Allurion Balloon.
|
$14.92M |
$2.00
-6.98%
|
|
AMS directly deploys and operates medical radiation therapy devices (Gamma Knife, LINACs, PBRT) in its Direct Patient Services centers.
|
$14.84M |
$2.30
-4.56%
|
|
REMONY remote monitoring and continuous vital-sign data collection align with patient monitoring.
|
$14.34M |
$2.14
+3.38%
|
|
Includes regulatory advisory and compliance support services, aligning with Laboratory Testing & Advisory Services as a service category.
|
$13.82M |
$0.60
|
|
NVNO's VenoValve is a surgically implanted device used to treat deep venous CVI, aligning with the 'Surgical Equipment' category.
|
$13.01M |
$0.74
-14.74%
|
|
Co-Diagnostics' core product is the Co-Dx PCR platform—a diagnostic instrument for portable, point-of-care PCR testing.
|
$12.92M |
$0.38
+3.59%
|
|
Offers diagnostic-ready sensor solutions (liquid-phase bio-chemical sensors) suitable for medical diagnostics and biomarker detection.
|
$12.75M |
$0.04
+2.94%
|
|
Mino-Lok is a proprietary antibiotic lock solution used as a catheter salvage consumable, a direct product offering.
|
$12.66M |
$1.23
-6.11%
|
|
Legacy Quarta-Rad product line includes Geiger counters / radiation detectors; mapped to Diagnostic Equipment as a product category.
|
$12.23M |
$0.80
|
|
The company uses a system-plus-consumables go-to-market model (system purchase plus consumables), indicating Medical Device Consumables as a revenue stream.
|
$11.78M |
$2.54
-5.58%
|
|
Diagnostic Equipment: imaging and analytics equipment used for threat detection and material identification.
|
$11.70M |
$0.62
+8.92%
|
|
MDxHealth offers liquid biopsy diagnostic tests (Select mdx, ExoDx) for prostate cancer and urinary tract infections, classifying them under Liquid Biopsy.
|
$11.13M |
$4.08
-7.06%
|
|
Check-Cap directly manufactures diagnostic equipment as part of its C-Scan system (capsule, wearable track, and viewing software) for CRC screening.
|
$10.77M |
$1.84
-8.00%
|
|
Woori IO's noninvasive CGM technology and OSRH's medical-device distribution align with Diagnostic Equipment.
|
$10.69M |
$0.55
-9.02%
|
|
AppYea directly manufactures/markets at-home wearables for sleep monitoring (AppySleep).
|
$10.37M |
$0.02
-13.97%
|
|
Handheld ballast water checker device functions as diagnostic equipment for compliance screening.
|
$10.36M |
$1.34
-1.45%
|
|
Company manufactures medical-grade silicon nitride materials and devices, central to its core medical device business.
|
$10.31M |
$4.11
+7.31%
|
|
MHUA lists medical imaging consumables (e.g., disposable X-ray films) as part of its product portfolio, aligning with Medical Imaging.
|
$10.18M |
$0.39
-6.47%
|
|
LYR-210 is an implantable prosthetic/implant delivering localized corticosteroid therapy, categorizing under Prosthetics & Implants.
|
$10.17M |
$7.67
-1.67%
|
|
Software relates to medical imaging/planning workflows used in radiotherapy, aligning with Medical Imaging software.
|
$10.15M |
$0.70
-1.14%
|
|
Ekso Bionics manufactures medical devices and biometric sensing technologies (exoskeletons for rehabilitation and mobility).
|
$9.56M |
$4.94
-8.86%
|
|
Core product line: liquid biopsy diagnostics using RNA in blood (VitaGuard MRD integration).
|
$9.32M |
$5.19
-3.71%
|
|
Recurring revenue from medical device consumables used with their equipment.
|
$9.24M |
$0.80
+5.81%
|
|
SCN-104 is an injection pen (drug-delivery device), aligning with Auto-Injector Devices.
|
$9.20M |
$0.70
-6.52%
|
|
DiamiR/Aptorum's combined diagnostics and biomarker panels imply Laboratory Testing & Advisory Services for biopharma customers.
|
$9.08M |
$1.66
-30.83%
|
|
ReWalk exoskeletons and related wearable mobility devices are prosthetics/implant-type products directly manufactured and sold by Lifeward.
|
$8.79M |
$0.80
-5.39%
|
|
Catamaran System and related sacroiliac/spine implants are orthopedic devices.
|
$8.65M |
$1.14
-4.20%
|
|
EsoGuard is a laboratory test/service delivered to clinicians, qualifying as Laboratory Testing & Advisory Services.
|
$8.61M |
$0.49
-13.83%
|
|
Laboratory testing and advisory services through CLIA-certified wet-lab operations supporting drug discovery.
|
$8.53M |
$14.32
+1.31%
|
|
Development and potential commercialization of diagnostic equipment/software (AI-enabled diagnostics).
|
$8.46M |
$0.00
-20.00%
|
|
Immco lab-based diagnostic testing and advisory services (lab testing, HIV screening, preeclampsia, etc.).
|
$8.05M |
$1.05
-3.67%
|
|
SpinDx and breathalyzer devices are diagnostic equipment directly manufactured/sold by Lifeloc Technologies.
|
$7.75M |
$3.16
|
|
The company manufactures a portable drug-screening system (IFPG) consisting of a handheld reader and disposable cartridges, i.e., diagnostic equipment.
|
$7.53M |
$1.09
-3.54%
|
|
The GE Healthcare diagnostic imaging equipment and ultrasound systems sold by VasoHealthcare fall under Diagnostic Equipment.
|
$7.48M |
$0.12
+2.27%
|
|
CDIO directly provides Laboratory Testing & Advisory Services through its in-house lab operations for epigenetic/genetic cardiovascular tests (EpiGen CHD, PrecisionCHD, ACI insights).
|
$7.22M |
$4.15
-7.37%
|
|
Biomerica directly manufactures and markets diagnostic tests (inFoods IBS, hpdetect, Fortel tests) and related point-of-care diagnostics.
|
$7.20M |
$2.83
-4.07%
|
|
NovaBay's continuing operations revolve around manufacturing wound care products for export to China, making Wound Care Devices its direct current product focus.
|
$7.15M |
$1.23
-0.81%
|
|
Cardiology devices: BioCardia's products are cardiac-focused delivery systems and cell therapies used in heart disease.
|
$7.04M |
$1.36
+0.37%
|
|
Boost Diagnostics and Pala Diagnostics provide diagnostic testing services, fitting Laboratory Testing & Advisory Services.
|
$6.85M |
$0.06
+23.91%
|
|
The narrative describes ongoing laboratory testing activities and regulatory/advisory services critical to bringing diagnostics to market.
|
$6.79M |
$0.04
|
|
Bionano's core offerings include Optical Genome Mapping hardware (Saphyr/Stratys) and the Ionic Purification System, both of which are diagnostic equipment sold to labs.
|
$6.76M |
$2.01
-1.95%
|
|
The WaveECG device is a diagnostic equipment product used for ECG-based cardiac assessment, which directly aligns with Diagnostic Equipment.
|
$6.75M |
$3.49
-6.43%
|
Showing page 4 of 5 (437 total stocks)
Loading industry metrics...
Loading comparison data...
